Agree Sav-J, very little to be taken seriously here….which is likely what the RMOH said when they saw Solascam’s clinical trial data for Ropren – more holes than Swiss cheese. Only people worth LOLing about are the Board of Directors of Solascam for not updating the market as to why June 30 has passed without Ropren approval after Denis Kilroy all-but-promised this would occur.
- Forums
- ASX - By Stock
- SLA
- intra day high
intra day high, page-12
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add SLA (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
SS1
SUN SILVER LIMITED
Gerard O'Donovan, Executive Director
Gerard O'Donovan
Executive Director
SPONSORED BY The Market Online